227 related articles for article (PubMed ID: 19022404)
1. Comparison of the immunomodulatory effects of the plant sterol beta-sitosterol to simvastatin in peripheral blood cells from multiple sclerosis patients.
Desai F; Ramanathan M; Fink CS; Wilding GE; Weinstock-Guttman B; Awad AB
Int Immunopharmacol; 2009 Jan; 9(1):153-7. PubMed ID: 19022404
[TBL] [Abstract][Full Text] [Related]
2. Changes in disease activity, cytokine production, and proliferation of peripheral blood mononuclear cells in patients with rheumatoid arthritis after simvastatin treatment.
Shirinsky IV; Zheltova OI; Solovyova NY; Kozlov VA; Shirinsky VS
Scand J Rheumatol; 2009; 38(1):23-7. PubMed ID: 18830905
[TBL] [Abstract][Full Text] [Related]
3. High dosage of simvastatin reduces TNF-alpha-induced apoptosis of endothelial progenitor cells but fails to prevent apoptosis induced by IL-1beta in vitro.
Henrich D; Seebach C; Wilhelm K; Marzi I
J Surg Res; 2007 Sep; 142(1):13-9. PubMed ID: 17716606
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Yokota K; Miyazaki T; Hirano M; Akiyama Y; Mimura T
J Rheumatol; 2006 Mar; 33(3):463-71. PubMed ID: 16511915
[TBL] [Abstract][Full Text] [Related]
5. Quercetin and interferon-beta modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients.
Sternberg Z; Chadha K; Lieberman A; Hojnacki D; Drake A; Zamboni P; Rocco P; Grazioli E; Weinstock-Guttman B; Munschauer F
J Neuroimmunol; 2008 Dec; 205(1-2):142-7. PubMed ID: 18926575
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors.
Waehre T; Yndestad A; Smith C; Haug T; Tunheim SH; Gullestad L; Frøland SS; Semb AG; Aukrust P; Damås JK
Circulation; 2004 Apr; 109(16):1966-72. PubMed ID: 15051633
[TBL] [Abstract][Full Text] [Related]
7. Impact of immunomodulatory treatment on leukocyte cytokine production in multiple sclerosis patients and healthy donors.
Reske D; Thomas AV; Petereit HF; Fink GR; Schroeter M
Neuroimmunomodulation; 2009; 16(6):385-91. PubMed ID: 19609087
[TBL] [Abstract][Full Text] [Related]
8. In vitro effect of statins on cytokine production and mitogen response of human peripheral blood mononuclear cells.
Bessler H; Salman H; Bergman M; Straussberg R; Djaldetti M
Clin Immunol; 2005 Oct; 117(1):73-7. PubMed ID: 16051523
[TBL] [Abstract][Full Text] [Related]
9. Interferon-beta modifies the peripheral blood cell cytokine secretion in patients with multiple sclerosis.
Mirandola SR; Hallal DE; Farias AS; Oliveira EC; Brandão CO; Ruocco HH; Damasceno BP; Santos LM
Int Immunopharmacol; 2009 Jul; 9(7-8):824-30. PubMed ID: 19289181
[TBL] [Abstract][Full Text] [Related]
10. Effect of interferon-beta and atorvastatin on Th1/Th2 cytokines in multiple sclerosis.
Sellner J; Greeve I; Findling O; Kamm CP; Minten C; Engelhardt B; Grandgirard D; Leib SL; Mattle HP
Neurochem Int; 2008 Jul; 53(1-2):17-21. PubMed ID: 18524417
[TBL] [Abstract][Full Text] [Related]
11. Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls.
Vanderlocht J; Hendriks JJ; Venken K; Stinissen P; Hellings N
J Neuroimmunol; 2006 Aug; 177(1-2):189-200. PubMed ID: 16797728
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin induces interleukin-18 production in human peripheral blood mononuclear cells.
Takahashi HK; Mori S; Iwagaki H; Yoshino T; Tanaka N; Nishibori M
Clin Immunol; 2005 Sep; 116(3):211-6. PubMed ID: 15936988
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1.
Sanna A; Huang YM; Arru G; Fois ML; Link H; Rosati G; Sotgiu S
Mult Scler; 2008 Nov; 14(9):1199-207. PubMed ID: 18653740
[TBL] [Abstract][Full Text] [Related]
14. Statins as modulators of colon cancer cells induced cytokine secretion by human PBMC.
Bergman M; Salman H; Djaldetti M; Bessler H
Vascul Pharmacol; 2011; 54(3-6):88-92. PubMed ID: 21440087
[TBL] [Abstract][Full Text] [Related]
15. HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells.
Kagami S; Kanari H; Suto A; Fujiwara M; Ikeda K; Hirose K; Watanabe N; Iwamoto I; Nakajima H
Int Arch Allergy Immunol; 2008; 146 Suppl 1():61-6. PubMed ID: 18504409
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
Turner NA; Midgley L; O'Regan DJ; Porter KE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis.
Zhang X; Tao Y; Troiani L; Markovic-Plese S
J Immunol; 2011 Sep; 187(6):3431-7. PubMed ID: 21856936
[TBL] [Abstract][Full Text] [Related]
18. Effect of vitamin D and β-sitosterol on immune function of macrophages.
Alappat L; Valerio M; Awad AB
Int Immunopharmacol; 2010 Nov; 10(11):1390-6. PubMed ID: 20728596
[TBL] [Abstract][Full Text] [Related]
19. Effects of simvastatin on cytokines secretion from mononuclear cells from critically ill patients with acute kidney injury.
Ferrari GL; Quinto BM; Queiroz KC; Iizuka IJ; Monte JC; Dalboni MA; Durão MS; Cendoroglo Neto M; dos Santos OF; Batista MC
Cytokine; 2011 May; 54(2):144-8. PubMed ID: 21367616
[TBL] [Abstract][Full Text] [Related]
20. Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases.
Kieseier BC; Archelos JJ; Hartung HP
Arch Neurol; 2004 Jun; 61(6):929-32. PubMed ID: 15210533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
